Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies-Reference-Cited by-同舟云学术

Developmental pharmacokinetics of sirolimus: Implications for precision dosing in neonates and infants with complicated vascular anomalies

Author:

Mizuno Tomoyuki¹,Fukuda Tsuyoshi¹²,Emoto Chie¹²,Mobberley-Schuman Paula S.³,Hammill Adrienne M.³²,Adams Denise M.⁴,Vinks Alexander A.¹²

Affiliation:

1. Division of Clinical Pharmacology; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

2. Department of Pediatrics, College of Medicine; University of Cincinnati; Cincinnati Ohio

3. Division of Oncology; Cancer and Blood Disease Institute, Cincinnati Children's Hospital Medical Center; Cincinnati Ohio

4. Boston Children's Hospital and Harvard Medical School; Boston Massachusetts

Funder

Japan Research Foundation for Clinical Pharmacology

Uehara Memorial Foundation

FDA Office of Orphan Products

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference26 articles.

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Pleural Diseases in Newborn Infants;Challenges in Pleural Pathology - Diagnostics, Treatment and Research;2024-07-10